The size of the laparoscopy devices market in North America is estimated to be growing at a CAGR of 7.08% from 2023 to 2028 and be worth USD 5.51 billion by 2028 from USD 3.91 billion in 2023. North America was the leading region in the global laparoscopy devices market in 2022, followed by Europe.
The adoption of laparoscopic devices among healthcare professionals is increasing with the growing advancements. The North American laparoscopy devices market is mainly driven by the adoption of subscription commerce-based models for product selling and increasing private and foreign investments. As a result, the manufacturers reduce the devices' pricing to remain competitive, fuelling the market growth. Due to the increase in the advancements and developments in the technology of laparoscopy surgery devices among healthcare professionals, the adoption of these devices is growing. The treatment with this device is affordable and provides a low risk of infections than open surgery. Because minimally invasive procedures produce less post-operative discomfort, patients require fewer painkillers. Because there are few incisions or sutures, the hospital stay is generally brief, and patients do not need to return to the hospital frequently.
The market for laparoscopic devices in North America is fiercely competitive, with several prominent competitors. Therefore, an increase in the number of market players like Johnson and Johnson (Ethicon Inc.) and ConMed Corporation by providing substitute products is accelerating the growth of laparoscopy devices in North America. Also, the rise in new technologies and developments is supporting market growth.
Due to the shortage of qualified surgeons to operate the advanced devices, as the devices are expensive and should be handled with care while performing the surgeries with the laparoscopic device, the factors mentioned above are expected to impose a negative impact on the market’s growth rate during the forecast period. Furthermore, if the technique is not performed correctly, it takes a more extended period to complete than open surgery. Also, the device provides limited mobility with loss of touch sensation, due to which people prefer other technologies present in the market. Furthermore, factors such as adverse effects like infection, risk of damaging internal structures, etc., and an increase in the use of robotics-assisted operations are further expected to limit the market growth of the devices in the North American region.
This research report on the North American laboratory devices market has been segmented and sub-segmented into the following categories:
By Product Type:
By Therapeutic Application:
By End Users:
Regionally, the United States is the largest market in North America and globally, followed by Canada. Increasing awareness in the region is the primary factor driving the market. The laparoscopic devices market in the United States was estimated to be worth USD 2.3 billion in 2020, with over 2.7 million laparoscopic operations conducted each year. Furthermore, the market is anticipated to expand at a prominent CAGR during the forecast period. It is all due to the advancements and new developments of the products with increased awareness about the devices. Obesity affects about 40 percent of American adults aged 20 and above. Overweight and obesity affect 71.6% of individuals aged 20 and above. The open Hasson entry technique is the most common laparoscopic primary entrance method utilized by general surgeons in Canada, which are 80.3% of the. Closed Veress- insufflated trocar and cannula entrance were reported by a lesser percentage of surgeons, 13.7%. Regardless of past abdominal surgery, Canadian general surgeons favor open periumbilical port insertion when doing an elective laparoscopic procedure such as a cholecystectomy. In obese patients, it appears that general surgeons prefer to put 65.4% of the supraumbilical ports rather than 22.6% of the infraumbilical ports. Around every year, over 15 million laparoscopic operations are performed worldwide, with the United States accounting for 32% of the total.
KEY MARKET PLAYERS:
Companies playing a dominant role in the North American laparoscopy devices market profiled in this report are Boston Scientific Corporation, Karl Storz, ConMed, Aesculap, Covidien, Olympus, Intuitive Surgical, Stryker, Medtronic, B. Braun Melsungen AG, Ethicon US LLC, and Smith & Nephew.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]